Optical Lipolysis System for Non-Invasive Fat Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for reducing body fat, such as behavior modification, pharmacological treatments, and surgical procedures like liposuction, are either ineffective, invasive, or associated with significant side effects and recidivism, while non-invasive methods like cryogenic devices provide delayed results and risk tissue damage.

Innovation Solution

A system utilizing an optical device with LEDs that emits radiation at a selective peak wavelength and power density for a specific time period to stimulate lipolysis in adipocytes, accompanied by a controller to determine optimal parameters for fat reduction and pain relief, without damaging surrounding tissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If surgical methods like liposuction are used to reduce fat, then fat reduction effectiveness is improved, but patient safety and tissue damage risk worsen

Engineering Contradiction:
Improvefat reduction effectivenessVSAvoidtissue damage risk
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces mechanical surgical intervention (liposuction) with optical energy (light) to achieve fat reduction. The optical device delivers specific wavelengths of light that penetrate the skin and stimulate lipolysis in adipocytes without mechanical contact, thereby eliminating risks of tissue damage, infection, and trauma associated with surgical methods while maintaining fat reduction effectiveness.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces optical energy as an intermediary between the external device and the adipose tissue. The light energy acts as a mediator that transfers energy to stimulate cellular metabolic processes (lipolysis) without direct mechanical or chemical contact with the tissue, thus achieving fat reduction while avoiding the harmful effects of direct intervention.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If behavior modification is used to reduce body fat, then patient safety is improved, but treatment effectiveness and compliance worsen

Engineering Contradiction:
Improvepatient safetyVSAvoidfat reduction effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSProductivity

Solution Approach 1:

The patent replaces behavioral modification (lifestyle changes, diet control) with optical therapy. Instead of relying on patient willpower and behavioral changes that have low compliance rates, the device uses optical energy to directly stimulate lipolysis in adipocytes, providing a passive treatment that achieves fat reduction without requiring significant patient effort or behavioral change.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The optical device enables the body's own metabolic systems to perform fat reduction. By delivering optical energy that stimulates cellular lipolysis enzymes, the treatment harnesses the body's natural metabolic processes to break down and eliminate fat, rather than requiring external behavioral modifications or pharmacological interventions.

Inventive Principle:
Principle #25Self-service

3Ease of operation

If cryogenic devices are used to reduce fat, then non-invasiveness is improved, but treatment speed and tissue safety worsen

Engineering Contradiction:
Improvenon-invasivenessVSAvoidtreatment delay
Core Design Contradiction:
Ease of operationVSLoss of time

Solution Approach 1:

The patent changes the physical parameter from extreme cold (cryogenics) to specific optical wavelengths. Instead of using extremely low temperatures that require long treatment times and risk frostbite, the device uses light at specific wavelengths that penetrate tissue and are absorbed by chromophores in adipocytes, converting optical energy to thermal energy at the cellular level to accelerate lipolysis without affecting surrounding tissues.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The optical device delivers energy selectively to adipose tissue while sparing surrounding structures. By choosing wavelengths that are preferentially absorbed by lipids and cellular chromophores, the treatment creates localized thermal effects within adipocytes to stimulate lipolysis, while the epidermis and dermis remain unaffected due to their different optical absorption characteristics.

Inventive Principle:
Principle #3Local quality

4Ease of operation

If pharmacological methods are used to reduce body fat, then treatment simplicity is improved, but side effects and effectiveness worsen

Engineering Contradiction:
Improvetreatment simplicityVSAvoidside effects
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The patent replaces pharmacological intervention with optical therapy. Instead of administering drugs that circulate systemically and affect multiple organs, the device delivers localized optical energy that is converted to thermal energy within adipocytes, stimulating lipolysis through localized heating without introducing chemicals into the body, thereby eliminating drug-related side effects.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system achieves rapid and effective fat reduction without adverse effects on tissues, improving skin appearance by stimulating lipolysis, collagen, and elastin production, while being non-invasive and suitable for both overweight and obese individuals.

Implementation Method 1

illuminate a region of the body at a selective peak wavelength and at a selective power density for a selective time period to stimulate lipolysis in the adipocytes

Methodology Applied
Scientific EffectLipolysis: Hydrolysis

Data Source

PatentUS9044595B2System and method for reducing lipid content of adipocytes in a body
Publication Date: 2015.06.02 BLUE WATER INNOVATIONS L L C
  • US9044595B2 patent drawing
  • US9044595B2 patent drawing
  • US9044595B2 patent drawing

AI summary

A system is provided for reducing lipid content of adipocytes in a body. The system includes an optical device configured to illuminate a region of the body at a selective peak wavelength and at a selective power density for a selective time period. The system also includes a controller connected to the optical device to determine the selective wavelength, the selective power density and the selective time period to stimulate lipolysis in the adipocytes. A system is also provided for reducing pain in the body. A method is also provided for reducing lipid content of adipocytes in the body.